Data from multiple sources - Curated by Toby Galbraith - Last updated 04 January 2017

Latest news articles

Added 1 month ago Drug news

Positive Phase III REVIVE-1 study of iclaprim in patients with acute bacterial skin and skin structure infections (ABSSSI).- Motif Bio.

Motif Bio plc announced positive topline results from REVIVE-1, a global Phase III clinical trial of its investigational drug candidate...

Added 5 months ago Drug news

Xydalba (dalbavancin) is launched in the UK as a treatment of acute bacterial skin and skin structure infections.- Cardiome Pharma

Cardiome Pharma Corp. announced that it has launched Xydalba (dalbavancin) in the UK earlier than expected. The European Medicines Agency...

View all news articles

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Hyperammonaemia

Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

Visit Hyperammonaemia

Guidelines

Surgical site infections: prevention and treatment

Surgical site infection is a type of healthcare-associated infection in which a wound infection occurs after an invasive (surgical) procedure....

Added 8 years ago

Antibiotic prophylaxis in surgery

The goals of prophylactic administration of antibiotics to surgical patients are to: - reduce the incidence of surgical site infection...

Added 8 years ago

View all guidelines

Journal articles

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

Acute bacterial skin and skin structure infections (ABSSSI) are a common disease causing patients to seek treatment through the health care system. With the continued increase of drug-resistant bacterial pathogens, ...

Added 26 days ago

Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic.

Dalbavancin, a recently approved glycopeptide antibiotic, whose disposition is not affected by renal function as compared to vancomycin is used to treat serious infections caused by Staphylococci and Streptococci ...

Added 26 days ago

Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors.

Skin and soft tissue infections are common reasons for medical care. Use of broad-spectrum therapy and costs have increased. Assessment of early treatment response has been given a central role both in clinical trials and everyday practice. 

Added 7 months ago

View all journal articles

CME

Facial ulcers in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Cellulitis: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0
View all CME